Article Details

ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic ...

Retrieved on: 2024-09-13 19:12:05

Tags for this article:

Click the tags to see associated articles and topics

ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic .... View article details on hiswai:

Summary

The article reports ENHERTU's (trastuzumab deruxtecan) efficacy in treating HER2-positive metastatic breast cancer with brain metastases, published in Nature Medicine. Tags highlight its relevance to breast cancer, antineoplastic drugs, and immunology, emphasizing novel drug conjugates and clinical study findings by Daiichi Sankyo.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up